Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Es-ketamine for postoperative analgesia and gastrointestinal dysfunction in elderly colorectal cancer surgery
ChiCTR2300070051Phase 4Not yet recruiting
- Sponsor
- Dazhou Central Hospital
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in colorectal cancer (CRC) and postoperative ileus (POI) (2 arms), sponsored by Dazhou Central Hospital. Primary endpoint: Duration of postoperative ileus. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
colorectal cancer (CRC)postoperative ileus (POI)
Beyond the preview
Go deeper on ChiCTR2300070051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070051.